Solazyme Reports First Quarter 2015 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Solazyme (SZYM) Expects H215 Revenue Acceleration on Product Line Expansion, New Product Introductions - Cowen
May 7, 2015 12:27 PM EDTCowen and Company maintains its Market Perform rating on Solazyme, Inc. (Nasdaq: SZYM) and moves its price target from $3 up to $4 following the company's Q1 announcement on Wednesday night.
Analyst Jeffrey Osborne noted that the firm was expecting Solazyme to report Q1 loss of $0.34 per share on revenue of $15.3 million, while the company actually reported Q1 loss of $0.37 per share and revenue of $12.6 million.
Osborne noted management... More
Solazyme (SZYM) Tops Q1 EPS by 3c
May 6, 2015 4:44 PM EDTSolazyme (NASDAQ: SZYM) reported Q1 EPS of ($0.37), $0.03 better than the analyst estimate of ($0.40). Revenue for the quarter came in at $12.6 million versus the consensus estimate of $16.7 million.
For earnings history and earnings-related data on Solazyme (SZYM) click here.
... More